Axsome Therapeutics, Inc.
Developing novel CNS therapies
- B2B
About Axsome Therapeutics, Inc.
Biopharmaceutical company focused on developing novel therapies for central nervous system conditions with limited treatment options, improving patient lives and providing more therapeutic options
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- New York, United States
- Founded
- 2012
- Revenue
- $638MFY2025, publicly reported
- Website
- axsome.com
- linkedin.com/company/axsome
Axsome Therapeutics, Inc. at a glance
Axsome Therapeutics, Inc. is a B2B company in the Biotechnology Research industry, headquartered in New York, United States.
Axsome Therapeutics, Inc. was founded in 2012.
Axsome Therapeutics, Inc. has 251–1,000 employees.
Axsome Therapeutics, Inc.'s revenue is $638M (FY2025, publicly reported).
Selling to companies like Axsome Therapeutics, Inc.?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies